Acceptance and Commitment Therapy for Trichotillomania: A Randomized Controlled Trial of Adults and Adolescents.


Journal

Behavior modification
ISSN: 1552-4167
Titre abrégé: Behav Modif
Pays: United States
ID NLM: 7803043

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 18 8 2018
medline: 9 4 2020
entrez: 18 8 2018
Statut: ppublish

Résumé

The purpose of this study was to examine acceptance and commitment therapy (ACT) as a standalone treatment for trichotillomania in a randomized controlled trial of adults and adolescents. Participants consisted of a community sample of treatment seeking adults and adolescents with trichotillomania. Of the eligible 39 participants randomized into treatment and waitlist groups, 25 completed treatment and were included in the final analysis. Treatment consisted of a 10-session ACT protocol. Multiple mixed models repeated measures analyses were utilized to evaluate changes in trichotillomania symptom severity, daily number of hairs pulled and urges experienced, and experiential avoidance from pretreatment to posttreatment. Findings indicated significant changes in symptom severity and daily hairs pulled, but not daily urges experienced or psychological flexibility. However, psychological flexibility saw a 24.5% decrease in the treatment group and reduced from clinical to subclinical levels on average. This study suggests that ACT alone is an effective treatment for adults and adolescents with trichotillomania. Outcomes appear to be similar to trials that combined ACT and habit reversal training (HRT).

Identifiants

pubmed: 30117327
doi: 10.1177/0145445518794366
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-91

Auteurs

Eric B Lee (EB)

Utah State University, Logan, UT, USA.

Kendra J Homan (KJ)

Cincinnati Children's Hospital Medical Center, OH, USA.

Kate L Morrison (KL)

Utah State University, Logan, UT, USA.

Clarissa W Ong (CW)

Utah State University, Logan, UT, USA.

Michael E Levin (ME)

Utah State University, Logan, UT, USA.

Michael P Twohig (MP)

Utah State University, Logan, UT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH